The association of sociodemographic and disease variables with hand function: a Scleroderma Patient-centered Intervention Network cohort study

Autor: Kwakkenbos L, Ta, Sanchez, Ka, Turner, Mouthon L, Me, Carrier, Hudson M, Chm, Den Ende, Aa, Schouffoer, Jjkc, Welling, Sauvé M, Bd, Thombs, Spin, The Investigators

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::45276da7707693cdf7aa6fd22d593e12
http://europepmc.org/abstract/med/30277865

Factors associated with physical function among people with systemic sclerosis: a SPIN cohort cross-sectional study.

Autor: Dal Santo T; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Department of Psychiatry, McGill University, Montreal, QC, Canada., Rice DB; Department of Psychology, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada., Carrier ME; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Virgili-Gervais G; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Levis B; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Kwakkenbos L; Department of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.; Department of IQ Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands., Golberg M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Bartlett SJ; Department of Medicine, McGill University, Montreal, QC, Canada.; Research Institute of the McGill University Health Centre, Montreal, QC, Canada., Gietzen A; National Scleroderma Foundation, Tri-State Chapter, Buffalo, NY, USA., Gottesman K; National Scleroderma Foundation, Los Angeles, CA, USA., Guillot G; Sclérodermie Québec, Longueuil, QC, Canada., Hudson M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Department of Medicine, McGill University, Montreal, QC, Canada., Hummers LK; Johns Hopkins University School of Medicine, Department of Medicine, Division of Rheumatology, Baltimore, MD, USA., Malcarne VL; Department of Psychology, San Diego State University, San Diego, CA, USA.; San Diego Joint Doctoral Program in Clinical Psychology, San Diego State University/University of California, San Diego, CA, USA., Mayes MD; Department of Internal Medicine, Division of Rheumatology, University of Texas McGovern School of Medicine, Houston, TX, USA., Mouthon L; Service de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Hôpital Cochin, Paris, France.; Assistance Publique Hôpitaux de Paris-Centre, Hôpital Cochin, Université Paris Cité, Paris, France., Richard M; Scleroderma Canada, Hamilton, ON, Canada.; Scleroderma Atlantic, Halifax, NS, Canada., Sauvé M; Scleroderma Canada, Hamilton, ON, Canada.; Scleroderma Society of Ontario, Hamilton, ON, Canada., Wojeck RK; College of Nursing, University of Rhode Island, Kingston, RI, USA., Geoffroy MC; Department of Psychiatry, McGill University, Montreal, QC, Canada.; Douglas Research Centre, McGill Group for Suicide Studies, Montreal, QC, Canada., Benedetti A; Department of Medicine, McGill University, Montreal, QC, Canada.; Research Institute of the McGill University Health Centre, Montreal, QC, Canada.; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada., Thombs BD; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Department of Psychiatry, McGill University, Montreal, QC, Canada.; Department of Medicine, McGill University, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.; Biomedical Ethics Unit, McGill University, Montreal, QC, Canada.; Department of Psychology, McGill University, Montreal, QC, Canada.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Oct 01; Vol. 63 (10), pp. 2660-2669.

Moderators of Loneliness Trajectories in People with Systemic Sclerosis During the COVID-19 Pandemic: A SPIN COVID-19 Cohort Longitudinal Study.

Autor: Rapoport CS; SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA., Choi AK; SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA., Kwakkenbos L; Department of Clinical Psychology, Radboud University, Nijmegen, the Netherlands.; Department of IQ Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands., Carrier ME; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Henry RS; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Department of Psychiatry, McGill University, Montreal, QC, Canada., Levis B; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada., Bartlett SJ; Department of Medicine, McGill University, Montreal, QC, Canada.; Research Institute of the McGill University Health Centre, Montreal, QC, Canada., Gietzen A; National Scleroderma Foundation, Tri-State Chapter, Buffalo, NY, USA., Gottesman K; National Scleroderma Foundation, Los Angeles, CA, USA., Guillot G; Sclérodermie Québec, Longueuil, QC, Canada., Lawrie-Jones A; Scleroderma Australia, Melbourne, VIC, Australia.; Scleroderma Victoria, Melbourne, VIC, Australia., Mayes MD; Department of Internal Medicine, University of Texas McGovern School of Medicine, Houston, TX, USA., Mouthon L; Service de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.; APHP-CUP, Hôpital Cochin, Paris, France., Richard M; Scleroderma Atlantic, Halifax, NS, Canada., Worron-Sauvé M; Scleroderma Society of Ontario, Hamilton, ON, Canada.; Scleroderma Canada, Hamilton, ON, Canada., Benedetti A; Department of Medicine, McGill University, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montreal, QC, Canada., Roesch SC; SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.; Department of Psychology, San Diego State University, 6363 Alvarado Ct., Ste. 103, San Diego, CA, 92120, USA., Thombs BD; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.; Department of Psychiatry, McGill University, Montreal, QC, Canada.; Department of Medicine, McGill University, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada.; Biomedical Ethics Unit, McGill University, Montreal, QC, Canada., Malcarne VL; SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA. vmalcarne@sdsu.edu.; Department of Psychology, San Diego State University, 6363 Alvarado Ct., Ste. 103, San Diego, CA, 92120, USA. vmalcarne@sdsu.edu.

Publikováno v: International journal of behavioral medicine [Int J Behav Med] 2024 Jun; Vol. 31 (3), pp. 352-362. Date of Electronic Publication: 2024 Jan 18.

Validity, Reliability, and Differential Item Functioning of English and French Versions of the 10-Item Connor-Davidson Resilience Scale in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.

Autor: Neyer MA; Lady Davis Institute of the Jewish General Hospital and McGill University, Montreal, Quebec, Canada., Henry RS; Lady Davis Institute of the Jewish General Hospital and McGill University, Montreal, Quebec, Canada., Carrier ME; Lady Davis Institute of the Jewish General Hospital, Montreal, Quebec, Canada., Kwakkenbos L; Radboud University Medical Center, Nijmegen, The Netherlands., Wojeck RK; University of Rhode Island, Kingston, Rhode Island., Gietzen A; National Scleroderma Foundation, Tri-State Chapter, Buffalo, New York., Gottesman K; National Scleroderma Foundation, Los Angeles, California., Guillot G; Sclérodermie Québec, Longueuil, Quebec, Canada., Lawrie-Jones A; Scleroderma Australia and Scleroderma Victoria, Melbourne, Victoria, Australia., Mayes MD; University of Texas McGovern School of Medicine, Houston., Mouthon L; Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France., Nielson WR; Western University and Lawson Research Institute, London, Ontario, Canada., Richard M; Scleroderma Atlantic, Halifax, Nova Scotia, Canada., Worron-Sauvé M; Scleroderma Society of Ontario and Scleroderma Canada, Hamilton, Ontario, Canada., Harel D; New York University, New York, New York., Malcarne VL; San Diego State University and University of California, San Diego., Bartlett SJ; McGill University, Montreal, Quebec, Canada., Thombs BD; Jewish General Hospital and McGill University, Montreal, Quebec, Canada.

Publikováno v: Arthritis care & research [Arthritis Care Res (Hoboken)] 2023 Nov; Vol. 75 (11), pp. 2369-2378. Date of Electronic Publication: 2023 Jun 07.

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.

Autor: Spiera R; Weill Cornell Medical College, New York, New York., Kuwana M; Nippon Medical School Graduate School of Medicine, Tokyo, Japan., Khanna D; University of Michigan, Ann Arbor., Hummers L; John Hopkins University School of Medicine, Baltimore, Maryland., Frech TM; University of Utah and Salt Lake City VA Health Care System, Salt Lake City, Utah., Stevens W; St. Vincent's Hospital, Melbourne, Victoria, Australia., Matucci-Cerinic M; Department of Experimental and Clinical Medicine, University of Florence, and Division of Rheumatology AOUC, Florence, and Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Milan, Italy., Kafaja S; David Geffen School of Medicine at University of California, Los Angeles (UCLA)., Distler O; University Hospital Zurich, University of Zurich, Zurich, Switzerland., Jun JB; Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea., Levy Y; Meir Medical Center, Kfar Saba, Israel., Leszcyzński P; Medyczne Centrum Hetmanska, Poznan, Poland., Gordon J; Weill Cornell Medical College, New York, New York., Steen V; Georgetown University School of Medicine, Washington, DC., Lee EB; Seoul National University College of Medicine, Seoul, South Korea., Jankowski T; Klinika Reumatologii Ukladowych Chorob Tkanki Lacznej Szpital Uniwersytecki, Bydgozzcz, Poland., Litinsky I; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel., Chung L; Stanford University School of Medicine and Palo Alto VA Health Care System, Palo Alto, California., Hsu V; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey., Mayes M; McGovern Medical School, The University of Texas Health Science Center at Houston., Sandorfi N; Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Simms RW; Boston University School of Medicine, Boston, Massachusetts., Finzel S; Department of Rheumatology and Clinical Immunology, University Medical Center, Universitätsklinikum Freiburg, Freiburg, Germany., de Vries-Bouwstra J; Leiden University Medical Center, Leiden, The Netherlands., Constantine S; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts., Dgetluck N; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts., Dinh Q; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts., Bloom BJ; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts., Furst DE; Department of Experimental and Clinical Medicine, University of Florence, and Division of Rheumatology AOUC, Florence, Italy, David Geffen School of Medicine at UCLA, Los Angeles, California, and University of Washington, Seattle, UK., White B; Corbus Pharmaceuticals, Inc., Norwood, Massachusetts., Denton CP; UCL Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital Campus, University College London Medical School, London, UK.

Publikováno v: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 Sep; Vol. 75 (9), pp. 1608-1618. Date of Electronic Publication: 2023 Jun 15.